Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
G1 Therapeutics Inc
(NQ:
GTHX
)
2.813
+0.193 (+7.35%)
Streaming Delayed Price
Updated: 10:01 AM EDT, Jun 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
471,350
Open
2.870
Bid (Size)
2.810 (2)
Ask (Size)
2.820 (25)
Prev. Close
2.620
Today's Range
2.760 - 2.890
52wk Range
2.380 - 17.49
Shares Outstanding
42,705,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy
June 04, 2023
From
G1 Therapeutics
Via
GlobeNewswire
New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer
May 16, 2023
Real-World Data Show No Association Between Patient Characteristics and Risk of Myelosuppressive Events
From
G1 Therapeutics
Via
GlobeNewswire
Performance
YTD
-50.91%
-50.91%
1 Month
-8.68%
-8.68%
3 Month
-22.73%
-22.73%
6 Month
-54.41%
-54.41%
1 Year
-36.79%
-36.79%
More News
Read More
New Results from Phase 2 Trial Confirm Benefit of Trilaciclib in Reducing Adverse Events Related to an Antibody Drug Conjugate (ADC)
May 10, 2023
From
G1 Therapeutics
Via
GlobeNewswire
Recap: G1 Therapeutics Q1 Earnings
May 03, 2023
Via
Benzinga
Earnings Preview: G1 Therapeutics
May 02, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About G1 Therapeutics
April 19, 2023
Via
Benzinga
7 Analysts Have This to Say About G1 Therapeutics
March 02, 2023
Via
Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, May 9, 2023: BABA, TSM, LCID, H, GTHX
May 09, 2023
Via
Benzinga
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights
May 03, 2023
From
G1 Therapeutics
Via
GlobeNewswire
Earnings Scheduled For March 1, 2023
March 01, 2023
Via
Benzinga
G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
March 01, 2023
From
G1 Therapeutics
Via
GlobeNewswire
G1 Therapeutics's Earnings Outlook
February 28, 2023
Via
Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
Via
Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
Via
Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
Via
Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
Via
Benzinga
Why Is Monday.com (MNDY) Stock Up 11% Today?
February 13, 2023
Via
InvestorPlace
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
February 13, 2023
Via
InvestorPlace
Why Is Sorrento Therapeutics (SRNE) Stock Down 40% Today?
February 13, 2023
Via
InvestorPlace
Why Is G1 Therapeutics (GTHX) Stock Down 52% Today?
February 13, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 13, 2023
Via
InvestorPlace
G1 Therapeutics Shelves Pivotal Colorectal Trial, After Trilaciclib Triplet Therapy Favored Placebo Arm
February 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.